Syneos Health

Syneos Health, a US-based Research and Development Services (73) company, has reported its carbon emissions for 2024 and 2023.

In 2024, the company's total reported emissions were approximately 218.7 million kg CO2e. This included Scope 1 emissions of about 16.5 million kg CO2e, Scope 2 emissions (market-based) of approximately 5.1 million kg CO2e, and Scope 3 emissions totalling around 197 million kg CO2e. Key contributors to Scope 3 emissions in 2024 were purchased goods and services (approximately 172.5 million kg CO2e) and business travel (about 36.9 million kg CO2e).

For 2023, Syneos Health reported total emissions of approximately 275.1 million kg CO2e. This comprised Scope 1 emissions of about 16.3 million kg CO2e, Scope 2 emissions (market-based) of around 9.7 million kg CO2e, and Scope 3 emissions totalling approximately 249.1 million kg CO2e. In 2023, purchased goods and services accounted for roughly 196.2 million kg CO2e of Scope 3 emissions, with business travel contributing approximately 50.7 million kg CO2e.

Syneos Health is committed to climate action. The company has signed The Climate Pledge, aiming to achieve net zero carbon emissions by 2040. Furthermore, Syneos Health has set near-term targets to reduce its overall emissions by 5% and Scope 1 and 2 emissions by 10% by 2026, relative to a 2021 baseline. More specifically, Syneos Health has committed to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42.0% by 2030 from a 2023 base year, as recognised by the Science Based Targets initiative (SBTi). The company also aims to reduce absolute Scope 3 greenhouse gas emissions from purchased goods and services and business travel by 25.0% within the same timeframe. These SBTi targets are aligned with a 1.5°C warming scenario.